1. The effect of antidiuretic hormone (ADH) on isoprenaline-stimulated renin secretion was examined in the isolated rat kidney perfused with modified Krebs-Ringer saline.
Introduction
Antidiuretic hormone inhibits the effect on renin secretion of a variety of stimuli, including aortic constriction (Bunag, Page & McCubbin, 1967) , ureteral occlusion (Vander, 1968) and sodium depletion (Shade, Davis, Johnson, Gotshall & Spielman, 1973) . The design of these studies, however, has not permited precise localization of this inhibitory effect of ADH.'" Suppression of renin secretion has also been observed with another structurally unrelated vasoactive peptide, angiotensin I1 (Bunag et al., 1967; Vander & Geelhoed, 1965; Blair-West, Coghlan, Denton, Funder, Scoggins & Wright, 1971 ) and with catecholamines having predominantly alpha-adrenoceptor activity (Vandongen & Peart, 1974a) .
Recent studies, using an isolated rat kidney preparation, have shown that suppression of isoprenalinestimulated renin secretion by angiotensin I1 appeared independent of changes in renal perfusion pressure (Vandongen, Peart & Boyd, 1974; Vandongen & Peart, 1974b) .Although this observationminimiiesan important role for vascular baroreceptors, a relation between the vasoconstrictor and renin-inhibitory activities of angiotensin I1 nevertheless exists as only the biologically active pressor form suppressed renin secretion. The independence of renin inhibition and raised perfusion pressure has been supported by the recent finding that a low calcium concentration in the renal perfusion medium abolishes renal vasoconstriction but does not prevent the inhibitory effect of angiotensin I1 on renin secretion (Vandongen & Peart, 1974b ).
The present study was undertaken to determine if ADH, like angiotensin 11, has an intrarenal inhibitory effect on renin secretion and to relate this to changes in renal perfusion pressure.
Methods

Kidney perfusion
Male Wistar rats (250-350 g) maintained on a regular diet were anaesthetized with sodium pentobarbitone (0.4 pmol/g intramuscularly) and given heparin (50-100 units intravenously). The left kidney was cannulated and perfused without interruption of blood flow as previously described (Vandongen, Peart & Boyd, 1973) . Krebs-Ringer saline (Ca 3.7 mmol/l; K 6 mmol/l; Mg 1.2 mmol/l) with dextran 36 g/l (mol. wt. 70 000; Pharmacia), oxygenated with 0 2 + C 0 2 (95:5, v/v) and maintained at 3 7 T , was delivered as pulsatile flow by a roller pump (WatsonMarlow). Perfusion pressure was recorded by a S.E. Lab transducer and Cardiotrace recorder. Flow rates were obtained by volume measurement of timed collections of effluent perfusate.
ADH (Vasopressin, Parke Davis and Co.) and isoprenaline (Isuprel, Winthrop) were diluted (1 60 mmol/l sodium chloride; saline) and infused into the arterial cannula at 0.03 ml/min. Doses are expressed per g of wet weight (non-perfused kidney).
At 6 min after the commencement of perfusion, the infusion of ADH or of saline as a control experiment was started. A collection of perfusate for determinationofreninconcentrationwasobtainedat 5,8,11,13 and 15 min.
Renin assay
Timed collections of perfusate were treated according to the method of Skinner (1967) for plasma renin activity. After incubation with nephrectomized rat plasma as renin substrate source (treated as sheep substrate by the method of Skinner), further reaction was terminated by heating at 85°C for 5 rnin and the samples were assayed for angiotensin I by radioimmunoassay (Boyd, Adamson, Fitz & Peart, 1969) using Aspl-IleS-angiotensin I (Schwarz Bioresearch) as standard. All samples from one experiment were processed and assayed at the same time. Renin concentration is expressed in nmol equivalents of Asp' -Iles angiotensin I generated per h per 1 of perfusate and converted into secretion rates by multiplying by the flow rate (rnlimin). All values shown are mean value ~S E M .
Results
The effect of isoprenaline (0.05 nmol min -'g -I ) on renin secretion and renal perfusion pressure is shown in Table 1 . Renin secretion is significantly increased compared with the 5 min value at the times indicated (P<O.Ol at 11 and 13 rnin; P<O.OOl at 15 min). It has been previously shown that these changes can be readily distinguished from corresponding control values, which show a slight increase with time during the infusion of saline only (Vandongen & Peart, 1974a) . Mean perfusion pressure decreased gradually over this period (Table l) , and this is similar to that observed during the infusion of saline only. During this fall in renal perfusion pressure, perfusate flow rate increased from 8 f0.5 ml/min at 5 min to 10.9k0.5 ml/min at 15 min (P<O.Ol).
As shown in Table 1 , infusing ADH at a dose (8 munits rnin -'g -') which was sufficient to raise renal perfusion pressure prevented stimulation of renin secretion by isoprenaline (0.05 nmol min -'g -I ) with levels significantly lower (at 11 rnin, P i 0.05), or not significantly different from, the 5 min value (at 13 and 15 min, P>0.05). It is readily seen that these levels are considerably less than those attained when isoprenaline was infused alone (Table 1) . This suppression of the stimulatory effect of isoprenaline on renin secretion by ADH is even more apparent when the changesfrom 8 rnin values inTables l(a) and l(b) are compared. No explanation for the higher renin at 5 min is available.
Renin secretion and renal perfusion pressure were not significantly changed after the infusion of ADH alone for 2 rnin compared with control values or the 5 rnin ADH value (P>O.O5). At 11, 13 and 15 min, however, mean perfusion pressure was consistently and significantly higher with ADH than with saline. Mean flow rate remained constant over the experimental period (7 f-0.6 ml/min at 5 min to 7.4 f-0.5 ml/min at 15 min, P>0.05).
Excluding calcium from the perfusion fluid and adding disodium EDTA (25 mmol/l) effectively prevented the rise in perfusion pressure when ADH was infused, resulting in mean perfusion pressures which were lower but not significantly different from control values. Basal renin secretion is considerably elevated under these conditions, confirming an earlier observation (Vandongen & Peart, 1974b) . After the introduction of isoprenaline (0.05 nmol min -'g -I), renin secretion then increases compared with the 5 min value (P < 0.05 at 11 and 15 min; P < 0.01 at 13 rnin), but it was only at 11 rnin that the change in renin secretion from 8 rnin levels was similar to that observed during the infusion of isoprenaline alone; at 13 and 15 min the increase in renin secretion was significantly less than control values despite a similar mean perfusion pressure. Mean flow rate did not change significantly over the experimental period (7.1 50.8 ml/min at 5 rnin to 8.6k0.3 ml/min at 9 min, P>0.05).
Discussion
This study demonstrates the effectiveness of ADH in suppressing isoprenaline-stimulated renin secretion. In addition, the use of the isolated kidney indicates that this inhibitory effect is mediated by an intrarenal site of action. Since other vasoconstrictor agents such as angiotensin I1 and alpha-adrenergic catecholamines also inhibit renin secretion, it seems conceivable that a mechanism common to all vasoconstrictors is responsible. Such a mechanism could involve local vascular receptors sensitive to increases in perfusion pressure (Skinner, McCubbin & Page, 1964 ) and the results presented here certainly appear to indicate a direct relation between the vasoconstrictor action of ADH and the suppression of renin secretion. Since renal perfusate flow rates remained unchanged during the infusion of ADH, it can be assumed that renal autoregulatory control was preserved. It remains possible, however, that redistribution of flow occurred under these conditions, resulting in relative underperfusion of the outer cortex where most renin is located. The role of the macula densa and changes in tubular sodium load appear to be unimportant in the inhibition of renin secretion by ADH (Shade et al., 1973) .
When the vasoconstrictor action of ADH was abolished by excluding calcium from the perfusion medium, renin secretion was significantly stimulated by isoprenaline but did not reach the levels observed when isoprenaline was infused alone. This is unlikely to be due directly to the absence of calcium ions as this has previously been shown not to impair the increase in renin secretion in response to isoprenaline (Vandongen & Peart, 1974b) . It is therefore conceivable that ADH has an inhibitory action on renin secretion which is at least partly independent of the rise in renal perfusion pressure.
The attenuation of the inhibitory effect of ADH on renin secretion in the absence of calcium is similar to that observed in a previous study with angiotensin I1 (Vandongen & Peart, 1974a) , although in these experiments the inhibitory effect of angiotensin was more completely dissociated from its vasoconstrictor effect. Any residual inhibitory activity, preventing renin levels reaching those observed with isoprenaline infused alone, could be mediated by intracellular calcium dissociated from intracellular binding sites by ADH in a manner similar to that reported for angiotensin I1 and noradrenaline (Baudouin-Legros & Meyer, 1972) . The importance of calcium in the contractile response of vascular smooth muscle (Somlyo & Somlyo, 1968) and its apparent involvement in the inhibitory effect of vasoconstrictor substances on renin secretion suggests that these activities may be commonly mediated by an intracellular calciumdependent process. The derivation of the juxtaglomerular cells, which produce renin, from vascular smooth muscle cells (Barajas & Latta, 1967 ) provides a morphological basis for this concept relating renin secretion and smooth muscle contractile activity. The marked increase in basal renin secretion in the absence of calcium observed in the present study was also reported previously (Vandongen & Peart, 1974b) and may indicate the existence of a calcium-dependent control mechanism limiting basal secretion. It is clear that these proposals require verification in the isolated juxtaglomerular cell where calcium flux can be directly determined. Furthermore, the relationship between the dose of ADH used in this study and the actual levels observed in arterial blood under physiological conditions will need to be established before a definitive role can be assigned to the intrarenal effect of ADH on renin secretion.
